Experts are calling on company to counter closed groups where members can post misinformation without challenge

Quick Read

A quiet but revolutionary new nat’l health policy goes into effect this week, ushering in changes that could lead to important medical discoveries that benefit most Americans. One problem. Implementing the change will require that our country’s health researchers make some fundamental changes in how they do business

Quick Read

The percentage of outpatient medical visits that led to a benzodiazepine prescription doubled between 2003 and 2015, according to a study published Friday. And about half those prescriptions came from primary care physicians

Quick Read

“The decision to continue to withhold this vaccine from pregnant women is not justifiable,” says our Ruth Faden, “We must listen to the voices of pregnant women in the midst of an outbreak. If they’re saying, ‘Give me the choice, I want to decide,’ how can we not respond to that? How could you not give them that choice?”

Quick Read

A new study shows that fentanyl test strips nudge drug users to take extra precautions

Quick Read

But some clinics stray from the science and hype its benefits. Walk into Kalypso Wellness Centers in San Antonio, Texas, and you might be treated with one of five “proprietary blends” of ketamine. They’re not cheap — $495 per infusion

Quick Read

The revised rules, proposed this week as part of the agency’s efforts to reduce “burdensome” federal regulations, would no longer penalize hospitals if too many of their patients die following transplants. St. Luke’s in Houston recently lost its Medicare funding for heart transplants for that very reason

Quick Read

A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them

Quick Read